Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Catanese

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Acta Neuropathologica|July 24, 2023
Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALSAmr Aly, Zsofia I Laszlo, Sandeep Rajkumar, et al.
EMBO Molecular Medicine|June 14, 2021
Synaptic disruption and CREB-regulated transcription are restored by K<sup>+</sup> channel blockers in ALSAlberto Catanese, Sandeep Rajkumar, Daniel Sommer, et al.
Molecular Autism|June 14, 2023
Shank2 identifies a subset of glycinergic neurons involved in altered nociception in an autism modelFlorian Olde Heuvel, Najwa Ouali Alami, Oumayma Aousji, et al.
Cell Reports|August 26, 2025
Activation of polo-like kinase 1 correlates with selective motor neuron vulnerability in familial ALSBarbara Szewczyk, Vitaly Zimyanin, Julia Japtok, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 28, 2026
RIG-I Mediated Neuron-Specific IFN Type 1 Signaling in FUS-ALS Induces Neurodegeneration and Offers New Biomarker-Driven Individualized Treatment Options for (FUS-)ALSMarcel Naumann, Theresa M Wierschin, Stefanie Kretschmer, et al.
Nature Communications|July 29, 2021
IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitroCaterina Prelli Bozzo, Rayhane Nchioua, Meta Volcic, et al.
The Journal of Experimental Medicine|March 22, 2024
A TBK1 variant causes autophagolysosomal and motoneuron pathology without neuroinflammation in miceDavid Brenner, Kirsten Sieverding, Jahnavi Srinidhi, et al.
Acta Neuropathologica Communications|June 26, 2026
A rare missense variant impacting NEK1 kinase function is associated with ALSDavid Brenner, Anna Ponomarenko, Iris Petrut, et al.
Annals of Neurology|August 9, 2025
Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral SclerosisChristina Steffke, Karthik Baskar, Franziska Bachhuber, et al.
Nature Communications|January 20, 2023
Integrative genetic analysis illuminates ALS heritability and identifies risk genesSalim Megat, Natalia Mora, Jason Sanogo, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Acta Neuropathologica|July 24, 2023
Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALSAmr Aly, Zsofia I Laszlo, Sandeep Rajkumar, et al.
EMBO Molecular Medicine|June 14, 2021
Synaptic disruption and CREB-regulated transcription are restored by K<sup>+</sup> channel blockers in ALSAlberto Catanese, Sandeep Rajkumar, Daniel Sommer, et al.
Molecular Autism|June 14, 2023
Shank2 identifies a subset of glycinergic neurons involved in altered nociception in an autism modelFlorian Olde Heuvel, Najwa Ouali Alami, Oumayma Aousji, et al.
Cell Reports|August 26, 2025
Activation of polo-like kinase 1 correlates with selective motor neuron vulnerability in familial ALSBarbara Szewczyk, Vitaly Zimyanin, Julia Japtok, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 28, 2026
RIG-I Mediated Neuron-Specific IFN Type 1 Signaling in FUS-ALS Induces Neurodegeneration and Offers New Biomarker-Driven Individualized Treatment Options for (FUS-)ALSMarcel Naumann, Theresa M Wierschin, Stefanie Kretschmer, et al.
Nature Communications|July 29, 2021
IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitroCaterina Prelli Bozzo, Rayhane Nchioua, Meta Volcic, et al.
The Journal of Experimental Medicine|March 22, 2024
A TBK1 variant causes autophagolysosomal and motoneuron pathology without neuroinflammation in miceDavid Brenner, Kirsten Sieverding, Jahnavi Srinidhi, et al.
Acta Neuropathologica Communications|June 26, 2026
A rare missense variant impacting NEK1 kinase function is associated with ALSDavid Brenner, Anna Ponomarenko, Iris Petrut, et al.
Annals of Neurology|August 9, 2025
Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral SclerosisChristina Steffke, Karthik Baskar, Franziska Bachhuber, et al.
Nature Communications|January 20, 2023
Integrative genetic analysis illuminates ALS heritability and identifies risk genesSalim Megat, Natalia Mora, Jason Sanogo, et al.
Pageof 3